✦ LIBER ✦

Delay in imaging versus clinical response: A rationale for prolonged treatment with anti–tumor necrosis factor medication in early rheumatoid arthritis

✍ Scribed by Wakefield, Richard J. ;Freeston, Jane E. ;Hensor, Elizabeth M. A. ;Bryer, Domini ;Quinn, Mark A. ;Emery, Paul

Book ID: 101649939
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 67 KB
Volume: 57
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.23097

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Delayed treatment with tumor necrosis fa

Delayed treatment with tumor necrosis factor inhibitors in incomplete responders to synthetic disease-modifying anti-rheumatic drugs shows an excellent effect in patients with very early rheumatoid arthritis with poor prognosis factors

✍ Junko Kita; Mami Tamai; Kazuhiko Arima; Yoshikazu Nakashima; Takahisa Suzuki; Sh 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 177 KB

B cell depletion may be more effective t

B cell depletion may be more effective than switching to an alternative anti–tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti–tumor necrosis factor agents

✍ Axel Finckh; Adrian Ciurea; Laure Brulhart; Diego Kyburz; Burkhard Möller; Silvi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views

## Abstract ## Objective Patients with rheumatoid arthritis (RA) in whom the response to anti–tumor necrosis factor (anti‐TNF) therapy is inadequate have several therapeutic options, such as switching to an alternative anti‐TNF agent or initiating B cell–depleting therapy with rituximab (RTX). Alt

Interferon-γ release assay versus tuberc

Interferon-γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti–tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis

✍ Elizabeth C. Hsia; Neil Schluger; John J. Cush; Richard E. Chaisson; Eric L. Mat 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

An alternative, autonomic rationale for

An alternative, autonomic rationale for decreased risk of myocardial infarction in patients with rheumatoid arthritis responsive to anti–tumor necrosis factor therapy: Comment on the article by Dixon et al

✍ Andrew J. Holman 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 32 KB 👁 2 views

Evidence of radiographic benefit of trea

Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: A detailed subanalysis of data from the anti–tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study

✍ J. S. Smolen; C. Han; M. Bala; R. N. Maini; J. R. Kalden; D. van der Heijde; F. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views

Sustained elevation of interleukin-33 in

Sustained elevation of interleukin-33 in sera and synovial fluids from patients with rheumatoid arthritis non-responsive to anti-tumor necrosis factor: possible association with persistent IL-1β signaling and a poor clinical response

✍ Matsuyama, Yasushi; Okazaki, Hitoaki; Hoshino, Motoaki; Onishi, Sachiko; Kamata, 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 292 KB